|[November 04, 2013]
Research and Markets: Research Report: Coronary Stents Market in India 2013
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/vs2hcc/coronary_stents)
has announced the addition of the "Coronary
Stents Market in India 2013" report to their offering.
This latest market research report titled Coronary stents Market in
India 2013 states that manufacturers of coronary stents are experiencing
high demand for their products due to a number of factors. Since
cardiovascular diseases have become a common occurrence among the Indian
population and the healthcare infrastructure in the country is rapidly
improving, it has built a strong case for angioplasty procedures in the
country. Moreover, an increase in awareness and the willingness to spend
on healthcare is benefiting the market.
Also, advancements in technology such as the introduction of
bioabsorbable stents in the Indian market in December 2012 has made such
stents more acceptable to patients, thereby providing further stimulus
for market growth. With growth in the number of cath labs in the country
and their subsequent expansion to smaller cities and towns,
angioplasties will become ore accessible to patients and will aid in
further development of the market.
Products available in the market can be divided into two types - those
manufactured by MNCs that command high prices, and those manufactured by
domestic companies that are generally priced lower. It is the MNCs that
serve the majority of the market with almost all the big hospitals in
tier I cities, where most of the angioplasties are performed, preferring
to implant stents manufactured by foreign companies over those
manufactured by their Indian counterparts.
The general perception is that stents manufactured by MNCs are superior
in terms of quality and efficacy, whereas those manufactured by domestic
companies fail to attain similar high standards of quality. Also,
patients are generally unaware of the choices they have in terms of the
types of stents and the various brands that are available in the market,
and have to buy stents directly from the hospitals. Since profit margins
are higher in case of foreign-manufactured stents, hospitals push for
the sale of such stents rather than selling the Indian varieties.
Key Topics Covered:
Drivers & Challenges
- Opto Circuits (India) Ltd.
- Abbott Healthcare Pvt. Ltd.
- B. Braun Medical (India) Pvt. Ltd.
- Boston Scientific India Pvt. Ltd.
- India Medtronic Pvt. Ltd.
- MIV Therapeutics (India) Pvt. Ltd.
- Meril Life Sciences Pvt. Ltd.
- Relisys Medical Devices Ltd.
- Sahajanand Medical Technologies Pvt. Ltd.
- Vascular Concepts Ltd.
For more information visit http://www.researchandmarkets.com/research/vs2hcc/coronary_stents
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]